In The Press

Noctrix Health Announces Enrollment of First Patient in The RESTFUL Study and Publication of Positive Pilot Study Results

January 11, 2021

PLEASANTON, Calif., May 25, 2021 /PRNewswire/ — Noctrix Health, Inc. today announced that the first patient...

Read More

Noctrix Health granted FDA Breakthrough Device Designation for wearable Restless Legs Syndrome Therapy

August 28, 2020

SAN FRANCISCO, June 2, 2020 /PRNewswire/ — Noctrix Health, Inc., a privately held medical device company...

Read More

Noctrix Health, Inc. Completes $17M Million Series B Financing

June 2, 2020

SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ — Noctrix Health, Inc., a private medical device company,...

Read More